Castrate Resistant Prostate Cancer Therapeutics Market
Added: (Wed Nov 03 2021)
Pressbox (Press Release) -
Market Overview
•The Global Castrate Resistant Prostate Cancer Therapeutics Market is expected to grow at a CAGR of 8.4% during the forecasting period (2021-2028).
•Castration-resistant prostate cancer is stated as prostate cancer that is scattered to other parts of the body. There are several risk factors for castration-resistant prostate cancer, including genetic predisposition, unhygienic diet, geriatric population, medication exposure, and many sexual partners. The methods were available for the diagnosis for detection of castration-resistant prostate cancer, which includes prostate imaging, tumor marker, biopsy, and staging test. For CRPC treatment, docetaxel-based chemotherapy has been widely accepted by urologists and oncologists.
Download free sample: https://www.datamintelligence.com/download-sample/castrate-resistant-prostate-cancer-therapeutics-market